Skip to main content
Log in

Proliferative potential of meningiomas determined with the monoclonal antibody Ki-67

  • Regular Papers
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Summary

In 30 meningiomas we investigated the proliferation rate of various subtypes with the monoclonal antibody Ki-67. Frozen sections were incubated with Ki-67 antibody using a modified Alkaline Phosphatase anti-Alkaline Phosphatase (APAAP)-technique and evaluation of proliferation rate was done by cell counting. Meningiomas of the meningiotheliomatous, fibrous and angioblastic subtype without atypical histological findings contained 1% or less proliferating cells. In recurent tumors, in transitional and in anaplastic meningiomas there is a marked increase of proliferating cells up to 20%. The distribution of marked cells varies in recurrent tumors and anaplastic meningiomas, and a focal proliferation of tumor cells was seen in meningiomas from transitional type. Immunohistological labelling of proliferating cells in meningiomas may allow a more precise prediction of the proliferation potential of each meningioma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Burger PC, Shibata T, Kleihues P (1986) The use of the monoclonal antibody Ki-67 in the identification of proliferating cells. Am J Surg Pathol 10:611–617

    Google Scholar 

  2. Cordell JL, Falini B, Erber WN, Gosh AK, Adulaziz Z, MacDonalds S, Pulford KAF, Stein H, Mason DY (1984) Immunoenzymatic labelling of monoclonal anti-alkaline phosphatase. J Histochem Cytochem 32:219–229

    Google Scholar 

  3. Gerdes J, Schwab U, Lemke H, Stein H (1983)-Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31:13–20

    Google Scholar 

  4. Gerdes J, Dallenbach F, Lennert K (1984) Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol Oncol 2:365–371

    Google Scholar 

  5. Hoshino T, Nagashima T, Cho KG, Murovic JA, Zhang R, Davis RL, DeArmond SJ (1986) Proliferative potential of malignant and non-malignant meningiomas. J Neuropathol Exp Neurol 45:320

    Google Scholar 

  6. Lellé RJ, Heidenreich W, Stauch G, Gerdes J (1986) Bestimmung der Wachstumfraktion bei Mammakarzinomen mit Hilfe des monoklonalen Antikörpers Ki-67. Tumor Diagn Ther 7:181–185

    Google Scholar 

  7. Nagashima T, DeArmond SJ, Murovic J, Hoshino T (1985) Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues. Acta Neuropathol (Berl) 67:155–159

    Google Scholar 

  8. Petty AM, Kun LE, Meyer GA (1985) Radiation therapy for incompletely resected meningiomas J Neurosurg 62:502–507

    Google Scholar 

  9. Schlote W, Lang C, Möbius HJ (1987) Proliferationszentren im desmoplastischen Medulloblastom — Untersuchungen mit dem monoklonalen Antikörper dn Proliferation 1 (Klon Ki-67). Zentralbl Allg Pathol (in press)

  10. Vollmer E, Bourgopoulou V, Roessner A, Erwig H, Grundmann E (1985) Immunhistologische und elektronenmikroskopische Untersuchungen an Chordomen. Verh Dtsch Ges Pathol 69:633

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roggendorf, W., Schuster, T. & Peiffer, J. Proliferative potential of meningiomas determined with the monoclonal antibody Ki-67. Acta Neuropathol 73, 361–364 (1987). https://doi.org/10.1007/BF00688260

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00688260

Key words

Navigation